DTIL
NASDAQ
$7.36
Precision Biosciences Inc (DTIL)
Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company is headquartered in Durham, North Carolina.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $29.60 (+302.17%)
Market Cap
$227M
Free Cash Flow Yield
-25.83%
Beta (5Y)
0.63
Price Chart
Valuation
Market Cap$227M
Forward P/E11.78
P/S5.04
P/B2.84
Profitability
Total Revenue (TTM)$45M
Gross Profit (TTM)$45M
EBITDA-$38M
Profit Margin-96.7%
Operating Margin-83.7%
EPS-$3.70
Financial Health
Free Cash Flow Yield-25.83%
Growth & Risk
EPS 5Y CAGR-42.10%
Revenue 5Y CAGR+6.03%
Beta (5Y)0.63
Sharpe Ratio0.95